This Pennsylvania House resolution designates October 13, 2026, as "Metastatic Breast Cancer Awareness Day" to highlight the challenges faced by individuals with stage IV breast cancer. The measure formally recognizes the national #LightUpMBC campaign, which encourages landmarks to display teal, green, and pink lights in solidarity and promotes increased research funding for metastatic cases. By officially acknowledging this specific date and cause, the bill aims to raise public awareness about a condition that affects women when their cancer has spread to other parts of the body.
This House Resolution designates the week of September 20 through 27, 2026, as "Idiopathic Pulmonary Fibrosis Research and Awareness Week" in Pennsylvania. The bill aims to raise public understanding of this lung disease, which causes irreversible scarring and affects thousands of residents in the state. By officially recognizing this specific time period, the resolution encourages increased attention and support for improved diagnosis and treatment efforts.
This Pennsylvania House resolution designates the week of September 20 through 26, 2026, as "Surgical Technologist Week" to recognize the contributions of surgical technologists in the state. The measure directly affects surgical technologists working in hospitals and surgical centers by formally acknowledging their vital role in patient care. It does not create new laws or funding but serves as a symbolic gesture to honor these healthcare professionals, following a similar national observance.
This bill designates November 2026 as Pancreatic Cancer Awareness Month within the state of Pennsylvania. It aims to increase public understanding of the disease by encouraging educational programs and support initiatives for those affected. The resolution does not change laws or allocate funding but serves as a formal statement to highlight the importance of early detection and research.
This Pennsylvania House Resolution designates September 2026 as "ITP Awareness Month" to highlight Immune thrombocytopenia, a rare autoimmune condition that lowers platelet counts and increases bleeding risks. The bill aims to encourage research and support for the more than 50,000 people in the United States living with the disease, which affects women aged 30 to 60 more frequently than others. By officially recognizing the month, the resolution seeks to educate the public about the challenges of diagnosing and managing ITP, which often requires specialized medical treatments like blood transfusions or spleen removal. This measure does not change laws or allocate funding but serves as a symbolic gesture to raise visibility for patients and their families.
This Pennsylvania House Resolution officially designates September 2026 as Thyroid Cancer Awareness Month within the state. The bill does not create new laws, allocate funding, or change existing regulations; instead, it serves as a symbolic gesture to highlight the importance of thyroid health. By recognizing this specific month, the resolution aims to encourage public awareness and education regarding thyroid conditions and cancer prevention.
HB 75 amends Pennsylvania's Osteopathic Medical Practice Act to update the definition of "primary supervising physician" to include medical doctors (MDs) licensed by the State Board of Medicine, alongside osteopathic physicians (DOs). This change allows physician assistants to have either an MD or a DO as their primary supervising physician under a written agreement, expanding oversight options beyond current restrictions. The amendment takes effect 60 days after enactment and does not alter other provisions of the law.
HB 1127 authorizes Pennsylvania to join the Dentist and Dental Hygienist Compact, enabling dentists and dental hygienists licensed in Pennsylvania to practice in other participating states without obtaining separate licenses. The bill establishes a "Compact Privilege" that allows qualified professionals to practice across state lines while maintaining each state's regulatory authority over scope of practice and disciplinary actions. Key mechanisms include streamlined licensure pathways, shared disciplinary information between states, and protection of public health standards. This affects licensed dental professionals seeking to work in multiple compact states, particularly addressing workforce mobility and access to care.
HB 69 amends Pennsylvania's Cancer Drug Repository Program to allow unused, unopened cancer prescription drugs to be redistributed to indigent patients through approved pharmacies. The bill updates definitions (e.g., clarifying "cancer drug" includes drugs treating cancer or its side effects), requires drugs to be in original sealed packaging with unexpired dates, and mandates the State Board of Pharmacy to maintain a list of approved participating pharmacies. It also adds requirements for annual reporting and establishes procedures for restocking and dispensing drugs while maintaining safety standards. This directly affects indigent cancer patients seeking affordable medication and pharmacies participating in the program.
HB 1117 amends Pennsylvania's 1929 Administrative Code to redefine the Department of Drug and Alcohol Programs' responsibilities for addressing substance use disorders. The department must now develop a comprehensive State plan coordinating prevention, treatment, research, and education across all state agencies and local communities - including health, law enforcement, education, and workforce sectors - to avoid duplication. The plan requires annual review and updates, and mandates the department to provide assistance to local governments while collaborating with medical professionals on drug use guidelines. This change formalizes existing coordination efforts under a unified framework, directly affecting state agencies and local entities managing substance use disorder services.